Prenetics Global Ltd (PRE) stock

PRENasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as PRENW

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 10/30

$16.72−0.92 (-5.22%)

Close on Nov 12, 2026Market cap $282.13MP/E –Yield –

Prenetics Global ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Prenetics Global has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Prenetics Global's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-15 reverse split on May 1, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing